TARDBP and amyotrophic lateral sclerosis: In our discovery cohort, TDP-43 pathology in non-CNS peripheral tissues was detectable up to 2–14 years before ALS symptom onset in lymph nodes, 1–11 years in skin, and 1–2 years in the gastrointestinal tract (Figure 1B).